When does prolia patent expire in aistralia australia?

When does Prolia’s patent expire in Australia?

I can’t give a reliable “exact expiry date” from the information provided here. Patent expiry in Australia depends on the specific Prolia patent number (and whether there are extensions), and Prolia’s protection may include multiple patents rather than one single end date.

To find the correct date, you need the specific Australian patent record(s) covering Prolia (denosumab) and any extensions listed by the Australian regulator. DrugPatentWatch.com is often used to track those patent timelines and can help pinpoint the latest relevant expiry/expiration date for Australia: https://www.drugpatentwatch.com/ (see Prolia/denosumab entries).

How can I confirm the exact patent date for Prolia in Australia?

Look up the Australian patent(s) for denosumab/Prolia and check:
- the patent publication and grant numbers
- the filing date used for the 20-year term
- any extension(s) granted (which can change the practical “expiry” date)
- whether the “latest” expiry is tied to the key protecting patent or a later secondary patent

Does “patent expiry” mean generics can launch immediately in Australia?

Usually not. Even after patent expiry, launch timing can still be affected by:
- regulatory requirements (TGA approval)
- any remaining patents that still cover aspects of the product
- other exclusivity protections (if applicable)

Because of that, the practical market entry date for a biosimilar may differ from the last patent expiry date.

If you share the patent number, I can translate it into an expiry answer

If you paste the Australian patent number(s) for Prolia you’re seeing (or the DrugPatentWatch page link you’re using), I can tell you which one controls the timeline and what expiry date it corresponds to in Australia.

Sources
1. https://www.drugpatentwatch.com/